Adrenal disease

PRAP study—partial versus radical adrenalectomy in hereditary pheochromocytomas

Eur J EndocrinolPublished Retrospective cohort study

Authors' conclusion

In patients with hPCC undergoing PA, local recurrence rates are higher than after RA, but metastasis and disease-specific mortality are similar. Therefore, PA seems a safe method to preserve adrenal function in patients with hPCC, in cases of both synchronous and metachronous bilateral disease, when performed as a second operation.

Study context

Population
Patients with hereditary pheochromocytoma due to pathogenic variants in RET, VHL, NF1, MAX and TMEM127, 12 European centers (1974–2023)
Participants
256 patients
Exposure
Partial adrenalectomy vs radical adrenalectomy
  • Partial adrenalectomy (PA)n = 33
  • Radical adrenalectomy (RA)n = 223reference
Outcome
Main outcomes: recurrence, adrenal insufficiency, metastasis and mortality
Methodological detailsmulticentre, 12 European centers, stratified analysis by surgery type and initial presentation
  • Multicentre
  • 12 European centers
  • Stratified analysis by surgery type and initial presentation

Main finding

As reported in the abstract

Ipsilateral recurrence

P = 0.02

Observational data: associations, not effects.

Further findings

Events

OutcomePARAP value
Bilateral adrenalectomy (synchronous or metachronous)2875
Adrenal insufficiency in metachronous bilateral disease: PA first then RA vs PA second after prior RAP = 0.09
Bilateral adrenalectomy (synchronous or metachronous) — Overall bilateral adrenalectomy
103 patients (40%)
Bilateral adrenalectomy (synchronous or metachronous) — Adrenal insufficiency after PA among bilateral adrenalectomy
46%
  • Adrenal insufficiency in metachronous bilateral disease: PA first then RA vs PA second after prior RA: PA first, then RA 75%
  • Adrenal insufficiency in metachronous bilateral disease: PA first then RA vs PA second after prior RA: PA second, after prior RA 14%
  • Adrenal insufficiency in metachronous bilateral disease: PA first then RA vs PA second after prior RA: 3/4 vs 1/7

Metachronous contralateral disease in initial unilateral disease

Initial unilateral disease
191 patients
Developed metachronous contralateral disease (most commonly RET, VHL, MAX)
50 (26%)

Original publication

PRAP study—partial versus radical adrenalectomy in hereditary pheochromocytomas. Eur J Endocrinol. Published 22 August 2024. doi:10.1093/ejendo/lvae108

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.